Non-exenterative surgical management of recurrent endometrial carcinoma.

ABSTRACT:

Objective

To examine the role of non-exenterative secondary cytoreductive surgery (SCS) compared with non-surgical treatments and identify predictors of improved survival for patients with recurrent endometrial cancer (EC).

Methods

All patients undergoing primary surgical management for EC 1/1/2009-12/31/2017 who subsequently developed recurrence were retrospectively identified. Survival was determined from date of diagnosis of first recurrence to last follow-up and estimated using Kaplan-Meier method. Differences in survival were analyzed using Log-rank and Wald tests, based on Cox Proportional Hazards model.

Results

Among 376 patients with recurrent EC, median time to recurrence was 14.3 months (range, 0.2-102.2), post-recurrence median survival 29 months, median fo

SUBMITTER: Moukarzel LA 

PROVIDER: S-EPMC8319948 | biostudies-literature | 2021 Aug

REPOSITORIES: biostudies-literature